ARDX short interest
Ardelyx Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 27,676,626 |
|---|---|
| Change vs prior report | 2,074,085 (+8.1%) |
| Change over six months | +13.1% |
| Days to cover | 6.60 (sector: 3.78) |
| Average daily volume | 4,193,543 |
| Rank in Healthcare | #273 of 922 by days to cover |
ARDX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 27,676,626 | +8.1% | 6.60 | 4,193,543 |
| 2026-09-15 | 25,602,541 | +12.7% | 6.34 | 4,035,894 |
| 2026-08-31 | 22,716,201 | +1.3% | 6.14 | 3,702,478 |
| 2026-08-14 | 22,433,157 | -14.5% | 3.32 | 6,766,701 |
| 2026-07-31 | 26,239,226 | -0.0% | 11.00 | 2,384,531 |
| 2026-07-15 | 26,248,733 | +3.5% | 8.06 | 3,255,473 |
| 2026-06-30 | 25,366,491 | -5.8% | 4.04 | 6,281,916 |
| 2026-06-15 | 26,942,503 | +8.7% | 8.58 | 3,140,730 |
| 2026-05-29 | 24,776,898 | +3.9% | 9.67 | 2,562,304 |
| 2026-05-15 | 23,857,367 | +1.2% | 4.55 | 5,247,694 |
| 2026-04-30 | 23,569,074 | -1.9% | 7.30 | 3,228,135 |
| 2026-04-15 | 24,018,325 | -1.8% | 7.68 | 3,127,225 |
| 2026-03-31 | 24,462,758 | +12.7% | 6.81 | 3,591,016 |
| 2026-03-13 | 21,701,321 | -0.8% | 7.49 | 2,898,422 |
| 2026-02-27 | 21,868,223 | +6.6% | 4.09 | 5,349,891 |
| 2026-02-13 | 20,520,612 | +10.6% | 6.68 | 3,073,112 |
| 2026-01-30 | 18,557,299 | -15.0% | 3.74 | 4,965,903 |
| 2026-01-15 | 21,833,586 | -11.0% | 2.70 | 8,076,855 |
| 2025-12-31 | 24,541,228 | +18.8% | 8.84 | 2,775,388 |
| 2025-12-15 | 20,664,408 | +2.8% | 7.45 | 2,774,197 |
| 2025-11-28 | 20,101,736 | +8.3% | 7.57 | 2,656,151 |
| 2025-11-14 | 18,568,868 | -8.2% | 5.12 | 3,628,055 |
| 2025-10-31 | 20,225,907 | +5.8% | 4.44 | 4,557,492 |
| 2025-10-15 | 19,112,230 | -1.9% | 5.50 | 3,476,589 |
| 2025-09-30 | 19,480,138 | -1.4% | 6.18 | 3,149,742 |
import finzdata as yf
yf.Ticker("ARDX").short_interest # every report since 2017
yf.Client().short_interest(["ARDX"], start="2018-01-01")Healthcare short interest · ARDX price history · Who owns ARDX · All short interest